Telemedicine in the treatment of gestational diabetes: an observational cohort study on pregnancy outcomes and maternal satisfaction
Sara Montori, Francesca Lugli, Marcello Monesi, Gennaro Scutiero, Elena Forini, Pantaleo Greco, Rosita Verteramo- Endocrinology
- Endocrinology, Diabetes and Metabolism
- Internal Medicine
Abstract
Aims
Gestational diabetes treatment requires several outpatient consultations from diagnosis until delivery, in order to prevent hyperglycaemia, which is associated with maternal and foetal complications. There is limited evidence in the literature about telemedicine superiority in improving pregnancy outcomes of women with gestational diabetes. The primary aim of the study was to evaluate the maternal and foetal outcomes, while the secondary aim was to estimate the degree of satisfaction in gestational diabetes treatment, comparing telemedicine versus outpatient care.
Methods
This observational cohort study involved 60 consecutive women with gestational diabetes treated at the Diabetology Unit of Ferrara: 27 were followed‐up through a weekly remote control method (telemedicine group) and 33 in ambulatory clinics every two or three weeks (conventional group). After giving birth, 56 women replied to the modified Oxford Maternity Diabetes Treatment Satisfaction Questionnaire, to assess their satisfaction with diabetes care.
Results
No statistically significant differences were found in most of the maternal and neonatal parameters evaluated in both groups. The questionnaire scores were positive in all areas investigated. Telemedicine follow‐up made women feel more controlled (p = 0.045) and fit better with their lifestyle (p = 0.005). It also emerged that almost all women treated with telemedicine would recommend this method to a relative or a friend.
Conclusions
Telemedicine follow‐up proved to be safe both in terms of metabolic control and pregnancy outcomes; furthermore, it significantly decreased the need for outpatient consultations and increased women's satisfaction. Studying the impact of telemedicine is also necessary, considering the current difficulties associated with the Sars‐COV‐2 pandemic.